Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
2.

Anti-beta2-glycoprotein I autoantibodies and metabolic syndrome.

Borges RB, Bodanese LC, Mühlen CA, Repetto G, Viehe M, Norman GL, Staub HL.

Arq Bras Cardiol. 2011 Apr;96(4):272-6. Epub 2011 Feb 25. English, Portuguese, Spanish.

3.

[Immunosuppression with cyclophosphamide and fudarabine, with support of autologous CD-34+ stem cells, in the treatment of severe scleroderma].

Mühlen CA, Hinterholz EL, Garicochea B, Weingrill P, Barrios C, Fernandes MS, Dahmer R, Keiserman MW, Staub HL.

Rev Bras Reumatol. 2004 Apr;44(2):169-74. Portuguese.

PMID:
21503545

Supplemental Content

Loading ...
Support Center